Vantage Consulting Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-222	Closed	-$233K	–	143
2024 Q2	$233K	Sell	222 -22	-9%	-$21.3K	0.17%	133
2024 Q1	$235K	Sell	244 -33	-12%	-$31.4K	0.15%	152
2023 Q4	$243K	Sell	277 -5	-2%	-$4.12K	0.16%	133
2023 Q3	$232K	Sell	282 -25	-8%	-$19.6K	0.16%	140
2023 Q2	$221K	Sell	307 -13	-4%	-$10K	0.13%	179
2023 Q1	$263K	Hold	320	–	–	0.15%	128
2022 Q4	$231K	Sell	320 -39	-11%	-$28.8K	0.14%	153
2022 Q3	$247K	Sell	359 -66	-16%	-$41.5K	0.14%	120
2022 Q2	$251K	Buy	425 +66	+18%	+$42.9K	0.14%	124
2022 Q1	$251K	Sell	359 -31	-8%	-$19.6K	0.1%	135
2021 Q4	$246K	Buy	390 +15	+4%	+$9.22K	0.07%	181
2021 Q3	$227K	Sell	375 -49	-12%	-$30.4K	0.05%	170
2021 Q2	$237K	Buy	+424	New	+$215K	0.04%	150
2021 Q1	–	Sell	-153	Closed	-$74K	–	1225
2020 Q4	$74K	Buy	+153	New	+$82.6K	0.01%	288